Sugi Predict

Sugi Predict / Compounds / SCHEMBL2307409

SCHEMBL2307409

SCHEMBL2307409

COC(=O)[C@@H]1C[C@@H](N[C@H]2CC[C@@H](C)CC2)CN1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 2/20 0.40
▸ NR1H2 P55055 2/20 0.36
▸ NR1H3 Q13133 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MMP2 P08253 10/20 0.36
▸ ANPEP P15144 6/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ CYP1A2 P05177 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ CHRM3 P20309 1/20 0.34
▸ PEPD P12955 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2307831 1.00 CCR2 (0.40) CCR2NR1H2NR1H3ALDH1A1MMP2
SCHEMBL29389706 1.00 CCR2 (0.40) CCR2NR1H2NR1H3ALDH1A1MMP2
SCHEMBL4303999 0.90 ALDH1A1 (0.43) CCR2NR1H2NR1H3ALDH1A1MMP2
SCHEMBL4304000 0.90 ALDH1A1 (0.43) CCR2NR1H2NR1H3ALDH1A1MMP2
SCHEMBL3382254 0.89 CCR2 (0.39) CCR2NR1H2MMP2ANPEPCYP1A2
SCHEMBL3382246 0.89 CCR2 (0.39) CCR2NR1H2MMP2ANPEPCYP1A2
SCHEMBL5133167 0.89 CCR2 (0.39) CCR2NR1H2MMP2ANPEPCYP1A2
SCHEMBL5133170 0.89 CCR2 (0.39) CCR2NR1H2MMP2ANPEPCYP1A2
SCHEMBL2306832 0.86 CCR2 (0.44) CCR2NR1H2NR1H3ALDH1A1MMP2
SCHEMBL1266962 0.86 CCR2 (0.44) CCR2NR1H2NR1H3ALDH1A1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039622-B2 Melanocortin receptor agonists LG LIFE SCIENCES LTD. (KR) 2011-10-18 — — US disclosed
US-20110245500-A1 MELANOCORTIN RECEPTOR AGONISTS LG CHEM, LTD. (KR) 2011-10-06 — — US disclosed
US-20110237795-A1 MELANOCORTIN RECEPTOR AGONISTS LG CHEM, LTD. (KR) 2011-09-29 — — US disclosed
US-20110224219-A1 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD. (KR) 2011-09-15 — — US disclosed
EP-2350060-A2 MELANOCORTIN RECEPTOR AGONISTS LG Life Sciences Ltd (KR) 2011-08-03 — — EP disclosed
US-20100120783-A1 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCE LTD. (KR) 2010-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237795-A1 MELANOCORTIN RECEPTOR AGONISTS MC1R, MC3R, MC5R CCR2 470/4885NR1H2 539/4885NR1H3 560/4885
US-20110245500-A1 MELANOCORTIN RECEPTOR AGONISTS MC1R, MC3R, MC5R CCR2 470/4885NR1H2 539/4885NR1H3 560/4885
US-20100120783-A1 MELANOCORTIN RECEPTOR AGONISTS MC1R, MC3R, MC5R CCR2 470/4885NR1H2 539/4885NR1H3 560/4885
US-20110224219-A1 MELANOCORTIN RECEPTOR AGONISTS MC1R, MC3R, MC5R CCR2 470/4885NR1H2 539/4885NR1H3 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.